Teropavimab Biosimilar - Research Grade

Human

HIV-1ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

The HIV-1 envelope glycoprotein is a primary antigen for broadly neutralizing antibody research against the virus. The reagent here is an unconjugated, non-therapeutic analog of teropavimab, a recombinant monoclonal antibody recognizing HIV-1, for research use only. It is produced to in vivo standards with low endotoxin and offered in scalable milligram to gram quantities for high-throughput laboratories. The antibody supports viral neutralization functional assays, in vitro envelope-binding screens, and in vivo models investigating HIV-1 neutralization and protection. Reproducible, high-purity preparation supports reliable results across repeated and large-scale experiments. Its scalable supply and batch consistency suit programs that require uniform reagent across many studies.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks